19 Sep 2019
Preventive cardiology: what the interventional cardiologist needs to know in 2019
EuroIntervention Journal
Risk and aspirin, blood pressure, cholesterol, diabetes: read this article written by J.W. McEvoy and D. Mylotte
At the annual meeting of the European Society of Cardiology in Paris this year, interventional cardiologists may find occasion to attend sessions not related to their own subspecialty. On such occasions, one often finds that innovation in cardiovascular medicine is not limited to the interventional arena. While the turn of the millennium brought with it some concerns that advances in cardiovascular medicine could be faltering, new device technologies have since generated a renaissance of sorts in cardiovascular innovation. In fact, a similar rejuvenation is happening in preventive cardiology.
Given the pace of discovery in cardiovascular medicine, however, the modern canon has become far too vast for any one individual to master. Hence, the interventional community may not be aware of important advances in preventive cardiology. Herein, we provide a summary (in ABCD format) of pertinent preventive cardiology “news” for the busy interventionalist. A more comprehensive and lengthy review for the subspecialty cardiologist interested in, but not focused on, preventive cardiology can be found elsewhere.
Authors
J.W. McEvoy, D. Mylotte